186 related articles for article (PubMed ID: 21813167)
1. Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
Flaig TW; Wilson S; van Bokhoven A; Varella-Garcia M; Wolfe P; Maroni P; Genova EE; Morales D; Lucia MS
Urology; 2011 Oct; 78(4):863-7. PubMed ID: 21813167
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
Chalfin HJ; Kates M; van der Toom EE; Glavaris S; Verdone JE; Hahn NM; Pienta KJ; Bivalacqua TJ; Gorin MA
Urology; 2018 May; 115():82-86. PubMed ID: 29432873
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
Nini A; Hoffmann MJ; Lampignano R; Große Siemer R; van Dalum G; Szarvas T; Cotarelo CL; Schulz WA; Niederacher D; Neubauer H; Stoecklein NH; Niegisch G
Cytometry B Clin Cytom; 2020 Jul; 98(4):355-367. PubMed ID: 32212383
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells in patients with urothelial cancer.
Gallagher DJ; Milowsky MI; Ishill N; Trout A; Boyle MG; Riches J; Fleisher M; Bajorin DF
Ann Oncol; 2009 Feb; 20(2):305-8. PubMed ID: 18836088
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
Abrahamsson J; Aaltonen K; Engilbertsson H; Liedberg F; Patschan O; Rydén L; Sjödahl G; Gudjonsson S
Urol Oncol; 2017 Oct; 35(10):606.e9-606.e16. PubMed ID: 28676151
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC).
Bergmann S; Coym A; Ott L; Soave A; Rink M; Janning M; Stoupiec M; Coith C; Peine S; von Amsberg G; Pantel K; Riethdorf S
Oncoimmunology; 2020; 9(1):1738798. PubMed ID: 32391189
[TBL] [Abstract][Full Text] [Related]
7. Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer.
Karl A; Tritschler S; Hofmann S; Stief CG; Schindlbeck C
Eur J Med Res; 2009 Nov; 14(11):487-90. PubMed ID: 19948444
[TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
[TBL] [Abstract][Full Text] [Related]
9. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
10. In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
Cegan M; Kolostova K; Matkowski R; Broul M; Schraml J; Fiutowski M; Bobek V
Int J Clin Exp Pathol; 2014; 7(10):7164-71. PubMed ID: 25400813
[TBL] [Abstract][Full Text] [Related]
11. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
Guzzo TJ; McNeil BK; Bivalacqua TJ; Elliott DJ; Sokoll LJ; Schoenberg MP
Urol Oncol; 2012; 30(1):44-8. PubMed ID: 20005748
[TBL] [Abstract][Full Text] [Related]
12. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
14. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
15. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
Busetto GM; Ferro M; Del Giudice F; Antonini G; Chung BI; Sperduti I; Giannarelli D; Lucarelli G; Borghesi M; Musi G; de Cobelli O; De Berardinis E
Clin Genitourin Cancer; 2017 Aug; 15(4):e661-e666. PubMed ID: 28188046
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
[TBL] [Abstract][Full Text] [Related]
18. Vysis UroVysion for the detection of urothelial carcinoma.
Halling KC
Expert Rev Mol Diagn; 2003 Jul; 3(4):507-19. PubMed ID: 12877389
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis.
Gazzaniga P; Gradilone A; de Berardinis E; Busetto GM; Raimondi C; Gandini O; Nicolazzo C; Petracca A; Vincenzi B; Farcomeni A; Gentile V; Cortesi E; Frati L
Ann Oncol; 2012 Sep; 23(9):2352-2356. PubMed ID: 22351740
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
